DRD2 and breast cancer: Similar to thioridazine, haloperidol, another D2R‐selective antagonist, also resulted in enhancement of aripiprazole‐induced PARP cleavage (Fig. 2F), suggesting that D2R activation did not contribute to aripiprazole‐induced apoptosis in human breast cancer cells.